PMA device
Micra VR2 Transcatheter Pacing System
Medtronic, Inc. · Leadless Pacemaker (PNJ, Class III) · First FDA decision Apr 20, 2023, newest Apr 20, 2023Bradycardia and heart block
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "Micra VR2"
MAUDE reports
956
Brand "Micra VR2", since 2015
PubMed studies
1
Mentioning "Micra VR2"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Micra VR2 Transcatheter Pacing System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Micra VR2 Transcatheter Pacing System, Micra AV2 Transcatheter Pacing System, Micra VR2/AV2 Application SoftwarePMA supplement
P150033-S161 · Decided Apr 20, 2023 · 167 days after receipt · Normal 180 Day Track
Device type: Leadless pacemaker (PNJ) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Leadless PacemakersNational analysisReview closedCAG-00448NUpdated Sep 18, 2026
- Leadless PacemakersNational determinationOn the books20.8.4Updated Mar 4, 2021
Clinical trials
Device studies on ClinicalTrials.gov that name "Micra VR2", any status and sponsor, newest update first.
- Leadless Versus Conventional Pacemakers: Effects on Heart Function and Heart FailurePivotal-lookingNot yet recruiting
Karl Landsteiner University of Health SciencesAcademic, hospital or other
NCT07929467 · 760 participants (planned) · Start Nov 2027 · Primary completion Dec 2029
Device: Leadless pacemaker implantation; Conventional transvenous pacemaker implantation · For: Bradycardia; Atrioventricular Block; Heart Failure and 4 more
Sites: Sankt Pölten, Austria
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Micra VR2", and for the whole product code for context.
This brand
956 reports: 583 malfunction, 321 injury, 52 death
Whole product code PNJ
21,401 reports: 11,736 malfunction, 8,341 injury, 1,319 death
Newest reports for this brand
- Micra¿ VR2Injury
9612164-2026-05363 · Received Oct 30, 2026 · Event dated Oct 5, 2026
Device type: Leadless Pacemaker (PNJ)
Device problem as coded: Pacing Problem; Use of Device Problem; Capturing Problem; High Capture Threshold; Unstable Capture Threshold
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Micra¿ VR2Injury
9612164-2026-05339 · Received Oct 29, 2026
Device type: Leadless Pacemaker (PNJ)
Device problem as coded: High Capture Threshold
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Micra¿ VR2Malfunction
9612164-2026-05344 · Received Oct 29, 2026 · Event dated Oct 6, 2026
Device type: Leadless Pacemaker (PNJ)
Device problem as coded: High impedance
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2127-2025 · Started Jun 17, 2025 · Posted by FDA Jul 17, 2025
Reason given: A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no...
Cause as FDA categorized it: Software design · Device type: Programmer, Pacemaker (KRG)
Z-2128-2025 · Started Jun 17, 2025 · Posted by FDA Jul 17, 2025
Reason given: A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no...
Cause as FDA categorized it: Software design · Device type: Programmer, Pacemaker (KRG)
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Z-2492-2019 · Started Aug 6, 2019 · Posted by FDA Sep 9, 2019
Reason given: Medtronic is updating the Micra Instructions for Use (IFU) and the Micra Implant Procedure Tip Card to include specific information on the removal of the tether to release the Micra Pacemaker from the Micra Delivery System during implant.
Cause as FDA categorized it: Other · Device type: Leadless Pacemaker (PNJ)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Micra VR2"[tiab]. The summary above synthesizes these.
- Device longevity of a leadless pacemaker family.
Leal MA, Sheldon T, Escalante K, et al. · Future Cardiol · 2025
Other devices of this type
Also filed under product code PNJ.
- Aveir Leadless SystemAbbott Medical · PMA 2026
- Aveir VR Leadless SystemAbbott Medical · PMA 2026
- Micra Transcatheter Pacing SystemMedtronic, Inc. · PMA 2026
- Aveir DR Delivery Catheter (LSCD201)Abbott Medical · PMA 2026
- Medtronic Micra Transcatheter Pacemaker SystemMedtronic, Inc. · PMA 2017
- AVEIR VR Real-World Evidence StudyAbbott Medical · PMA 2026
- AVEIR AR 2 LSP203A Leadless Pacemaker (LP) (atrial)Abbott Medical · PMA 2025
- AVEIR Patient TransmitterAbbott Medical · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.